Surface Oncology | 4:持股变动声明-董事 Sigal Charles Elliott
Surface Oncology | 4:持股变动声明-高管 Adams Chandra
Surface Oncology | 4:持股变动声明-高管 RATH HENRY C.
Surface Oncology | 4:持股变动声明-董事 Goater Jeff
Surface Oncology | 4:持股变动声明-首席财务官 FEES JESSICA
Surface Oncology | 4:持股变动声明-首席执行官 ROSS ROBERT W.
Surface Oncology | 4:持股变动声明-董事 GRAYZEL DAVID S.
Surface Oncology | 4:持股变动声明-高管 ONEILL ALISON
Surface Oncology | 4:持股变动声明-高管 Adams Chandra
Surface Oncology | 4:持股变动声明-首席财务官 FEES JESSICA
Surface Oncology | 4:持股变动声明-高管 ONEILL ALISON
Surface Oncology | 4:持股变动声明-首席执行官 ROSS ROBERT W.
Surface Oncology | SC 13G:超过5%持股股东披露文件-ADAR1 Partners, LP(5.24%),ADAR1 Capital Management, LLC(5.24%)等
Surface Oncology | 4:持股变动声明-高管 RATH HENRY C.
Surface Oncology | 4:持股变动声明-首席执行官 ROSS ROBERT W.
Surface Oncology | 4:持股变动声明-高管 Adams Chandra
Surface Oncology | 4:持股变动声明-高管 ONEILL ALISON
Surface Oncology | 4:持股变动声明-首席财务官 FEES JESSICA
Surface Oncology | 4:持股变动声明-高管 Palombella Vito J.
Surface Oncology | SC 13G/A:超过5%持股股东披露文件(修正)-EcoR1 Capital, LLC(6.5%),Oleg Nodelman(6.5%)等
暂无数据
暂无数据